Santa Rosa Valley KAP For Bipolar 2 Disorder, SSRI Alternative Launched

Dec 13, 2023

Chrysalis Ketamine (888-836-4334) has announced its ketamine treatment for bipolar 2 disorder to serve patients in Santa Rosa Valley, near Thousand Oaks, CA.

Thousand Oaks, United States - December 13, 2023 /PressCable/ —

The clinic’s recently announced ketamine infusion therapy is intended as an alternative to traditional SSRIs, providing relief from the symptoms of bipolar 2 disorder. Research indicates that ketamine can relieve symptoms of depression and hypomania where other forms of medication have failed.

For more details, please visit https://chrysalisketamine.com/bipolar-disorder-thousand-oaks-ca/

Chrysalis Ketamine's new ketamine treatment option for bipolar 2 disorder works by rapidly boosting the activity of glutamate, a neurotransmitter responsible for learning and memory. Ketamine works much faster than typical antidepressant medications as it bypasses the conventional serotonin pathway, focusing solely on the glutamate pathway to regulate the nervous system.

“Ketamine therapy is remarkably different from conventional antidepressants, which ultimately boost serotonin activity levels in several areas of the brain to ultimately affect glutamate," Chrysalis Ketamine says. "This process usually takes weeks, sometimes months, while ketamine produces an almost instant result and relief from anxiety symptoms.”

As explained by Dr. Karpanian, patients with bipolar 2 disorder present with recurring episodes of major depression and hypomania (a milder form of mania). In a recent study by the Institute For Advanced Psychiatry, it was revealed that, of 42 patients with bipolar disorder, 52% responded favorably to a single ketamine infusion. In a similar study, 27 ketamine therapy patients reported relief from their depressive symptoms within a week, with 37% reporting remission.

Chrysalis Ketamine provides private treatment rooms for those undergoing ketamine infusion therapy and monitors patients regularly throughout. The clinic recommends that patients undergo at least two infusions in conjunction with any current ongoing psychiatric therapy.

A spokesperson for the clinic states: “Studies show that a protocol of six infusions over the span of two to three weeks provides the most benefit for patients. This can be followed by maintenance infusions given every few weeks to months as needed with the ultimate goal of not needing any further infusions.”

About Dr. Hagop Karpanian

Dr. Hagop Karpanian is a graduate of UC Berkley and the Medical College of Wisconsin. Having completed his anesthesiology residency at the University of Washington and a fellowship in cardiac anesthesiology at UCLA, Dr. Karpanian started private practice, opening Chrysalis Ketamine in Thousand Oaks, CA.

Interested parties can find more information by visiting https://chrysalisketamine.com/

Contact Info:
Name: Hagop Karpanian
Email: Send Email
Organization: Chrysalis Ketamine
Address: 430 E Avenida De Los Arboles Suite 205, Thousand Oaks, California 91360, United States
Phone: +1-888-836-4334
Website: https://www.chrysalisketamine.com

Source: PressCable

Release ID: 89116215

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected]. Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

More News

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Profit And Cost

Profit and Cost is the personal business & financial assistance for individuals considering to improve their profits and lowering the cost in their everyday life.

Newsletter

Subscribe for more recent news from Profit And Cost